Breaking News
Get Actionable Insights with InvestingPro+: Start 7 Day FREE Trial Register here
Investing Pro 0
Ad-Free Version. Upgrade your Investing.com experience. Save up to 40% More details

Canadian Cannabis Firm Gets Noticed With Q4 Earnings And Global Expansion Plans

By Investing.com (Brenda O'Farrell/Investing.com)Stock MarketsApr 04, 2019 08:36
ca.investing.com/analysis/canadian-cannabis-firm-gets-noticed-with-q4-earnings-and-global-expansion-plans-200198427
Canadian Cannabis Firm Gets Noticed With Q4 Earnings And Global Expansion Plans
By Investing.com (Brenda O'Farrell/Investing.com)   |  Apr 04, 2019 08:36
Saved. See Saved Items.
This article has already been saved in your Saved Items
 

In the world of cannabis stocks, the big boys are not the only players in the sector who are getting noticed. A case in point is Medipharm Labs Corp (V:LABS).

This company based in Barrie, Ont., which has been until now flying under the radar in many respects, specializes in what it terms research-driven extraction, distillation, purification and cannabinoid isolation. Yesterday, it unveiled its fourth-quarter results – and the numbers registered a blimp on the screen that got some attention. It’s revenues for the period ending Dec. 31, 2018, totalled $10.2 million.

But what is most significant is that these revenue figures were achieved from mid-November to the end of December, as the company only received its sales licence from Health Canada on Nov. 12. The month prior, it completed financing of more than $25 million and began trading on the Toronto Stock Exchange’s Venture exchange on Oct. 4, 2018. Later in the year, it was named the Cannabis Start Up of the Year for 2018 at the Canadian Cannabis Awards by Lift & Co.

“2018 was a breakthrough year for MediPharm Labs,” said company CEO Patrick McCutcheon in a statement released Wednesday. “We became the first fully licensed producer to specialize solely in extraction and quickly scaled operations to emerge as the dominant market leader in the manufacturing of high quality pharmaceutical-like production of cannabis derivative products – the future of cannabis.”

And that last part of McCutcheon’s comment is key: “Cannabis derivative products – the future of cannabis.” It is the part of the cannabis trade that is aimed at the beverage, food, wellness and pharmaceutical markets. And it is the ‘what’ and the ‘why’ many large U.S. companies are lining up to partner with Canadian producers in order to position themselves in this sector.

In other highlights from the company’s Q4 report, MediPharm Labs’ recorded a net loss of $3.5 million for the quarter and $8.5 million for the year.

MediPharm Labs shares opened yesterday at $3.83 and closed at $3.62. It has a market cap of $381.36 million. Shares have gained 248 percent in the last year.

Among MediPharm Labs notable highlights from 2018 was the start of construction of MediPharm Labs Australia’s cannabis extraction facility, which is licensed, and expected to go into production in the latter half of this year. This facility will serve as a hub for the Asia-Pacific regions.

Also this year, the company has secured more than $85 million in label sales agreements that cover a 15-month period beginning December 2018, and a $35-million private label cannabis oil sale that stretches over a 13-month period.

The company also plans to secure European Union certification at its Ontario plant in order to export to EU countries.

Canadian Cannabis Firm Gets Noticed With Q4 Earnings And Global Expansion Plans
 

Related Articles

Canadian Cannabis Firm Gets Noticed With Q4 Earnings And Global Expansion Plans

Add a Comment

Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

Write your thoughts here
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
Comments (1)
Rajeshwar Harchand
Rajeshwar Harchand Apr 05, 2019 10:13
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Thanks Brenda!
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures) and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn`t bear any responsibility for any trading losses you might incur as a result of using this data.

Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.
Continue with Google
or
Sign up with Email